Member Info for RorkesDrift

Water is a fluid - it flows, it can be pumped, filtered etc.

Air is a fluid.

Am I taking a step too far to suggest if you can monitor covid in water you can also measure it in air. The way the sewage system works is to let water flow over affimers within a "closed" box.

Where air is within a similar system - I'm thinking anywhere with air conditioning then air is pumped and filtered. Think of the button in your car - you can choose recirculated or fresh.

Aeroplanes would be an example. Some factory spaces.

However, doesn't need to be an enclosed space just air from a location with people in it.

The maths would involve total air volume, sample volume of air / minute, quantitative signal of covid particles. Think pollen filtration.

OK the nurse has just come in with my injection so I've got to go - it keeps me quiet

Thanks for that and the same to you and Wilson. If you have gift your head around SGN have a look at SWedish Bio. Have a IL1 receptor antagonist but don't tell anyone

Get in Spike. Great post.

Hard to see how it could be anything else

Lol - funny you should mention convalescent plasma. I bought CSL on that basis coupled with increasing flu vaccine demand. I also think their past shows they have a better chance than most at a covid vaccine. However, SP hasn't moved. You cannot win them all but feel money is at least well looked after

When FDA issuing EUA for devices with essentially no data our chances of getting through have to be higher with Condor. Politically its in Trump interest to be seen to implement especially cf. other countries.

RKnin normal non-pandemic situations you would be right possibly.

Mr ST. I agree. I have a mini sleepy Dave covid portfolio. With Avacta powering up its difficult to keep it balanced but all in woukd not suit me - **** or bust is more SKIN but I'm also SGNing and TILs. The historic drop from £2+ to £1 due to placing is part of it but most advice is diversification is just sensible especially when there are other opportunities in short term. That said Avacta is about 60% of my current holding and I await the rise - beware anyone who says any of this is certain - profits are only profits when the cash hits your bank account. My estimate is from £5+ with any stalling for a day to be a top slice consideration but will be disappointed if sell any below £10. Avactas SP really now depends on external and competition factors - PEST and 5 forces more important than ever. SKIN appears in both more than once !!!!

Our partner SKIN is up again this morning on rumours of a breath test.

That's almost a three bagger since we first heard about them. At this rate we will soon have a four SKIN out of this.

I often think its not the number of posts but the length of a post. A sage like tone should be adopted as if the poster is using a pipe to point and add emphasis whilst keeping the other hand either in a cardigan pocket or laid flat on a convenient mantelpiece

Humour should be left to those working down stairs since it detracts from the overall ambiance of a serious and well researched investment approach although reference to ones own enormous handful is important to demonstrate commitment. Indeed adding a 0 is considered in many arenas to be just good form.

One should look to ones local congregation to add a level of endorsement which acts to establish validity. Perfuse thanks as they genuflect and prostate themselves is important if the full affect of investment guru is to be achieved. I would add several more paragraphs but I fear they would just be worms roxanne

I have considered this and we know there are many different potential inflection points along the way which I have built in. Anyone with any doubts should ignore these - they are the devils work. If you just believe that every thing will go to plan and much faster than prof Al says and keep topping up from your hard earned life savings I can guarantee the share price will go up. It is important that you continue to hang in there whilst i offload my holding at an inflated price which is why I bang on about the long term potential and importance of you holding

A drop with all this news signposted. Its almost as if professional investment companies that have millions to so end on company analysis would be better off just reading RK post - £37 here we come - bit of a gap and plenty of opportunity for anyone who wants to get out to do so

Lol - RK I'm guessing you are planning on selling in October then (BMN?)

Thanks for posting - Great find

DO NOT PUT AnY MONEY IN THAT YOU CANNOT AFFORD TO LOSE.

No one on here can offer investment advice so I agree on balance listening to BB is dangerous. Plenty of examples of shares being pumped and dumped especially when MKT caps are low. I have absolutely no idea whether SKIN will go up or down but I am taking that risk. Part of that is influenced by post annual report developments including uplift to revenues

January: Cooperative alliance agreement with Innocare Group, Shanghai, China;
• February: First RAWTest commercial agreement and AI partnership with Acumen Software of South Africa;
• February: Launch of ecowaterOS consortium for real-time water monitoring, recovery, treatment and recycling;
• March: 3 year, $3.75m (£3.12m) bacteria production agreement with Modern Water plc;
• March: Labskin expand York UK Laboratories by 100% to meet increased demand;
• March: Production commenced of bacteria to detect water contamination amid COVID-19 public health crisis;
• March: c£2m confirmed orders in Q1, 2020 leading to new investment of £250,000 to ramp-up production;
• May: Double production of Modern Water reagent bacteria to meet increased demand;
• May: RAWTest AI real-time alert system to be retrofitted in new Modern Water's Microtox units;
• June: Labskin partners with University of Aberdeen to test COVID19 anti-viral skin and dental products.

Apologies oncosil device

Hope this info might help. CE mark including UK earlier this year.

https://www.agreementstates.org › ...PDF
Web results
An Introduction to OncoSil™ for Treating ...

I am not convinced people will have to pay for tests. Two alternatives are

1 Government provides. The emergence of population surveillance has already begun - postcodes of anyone attending NHS are already know. Furthermore, if there was some substance that infected people produced that was collected normally on mass we could monitor viral presence in the community.

2. Employers. It would seem within normal H&S that employers adopt practices that keep their work force safe. If testing were done on a Monday am and Wednesday pm. Merge these two and the government could subsidise companies or facilitate test provision.

3. Prescription. Massive groups would then not have to pay and tests would be readily available from pharmacist. Many have space where individuals could wait. The rest of us could pay £10.20 or whatever current prescription charge is.

In terms of people reporting positive results the current aim is to drive the R number below 1. I think the majority of people would isolate at least. Self employed are in a more difficult situation but some form of support for individuals testing positive would help.

https://en.wikipedia.org/wiki/3C-like_protease

I am a technosaurus and cannot teach this phone how to spell affirmers

What we know so far is making LFTs is not as simple or as quick as we think. However, Avacta may have several advantages

1. Affimers may improve performance compared to antibodies. Smaller so you might be able to put more on a given area, it may be that they also orientate so that more can be packed in.

2. They seem to have started before most of the competition.

3. They choose a highly capable partner. Klaus is part of the team.

4. They had a Zika test - that would have reduced learning curve

5. Affirmers are quicker to identify than Abs and are simpler to produce end masse and consistently.

6. We know they are already in the best testing scheme in the world - supports regulatory approval if we pass

7. They are from Yorkshire.

Seadog - that is easily a Centurion making post. If it is Avacta you would think that it should be an RNS. Interesting assessment design - gives us an idea of how they see testing running in the future (note to self to dig out previous post, insert big yellow sticky out tongue head).

Big thanks for heads up - huge news. If you could extend it over six paragraphs you might get an extra 40 recs.